AbbVie Inc. is 353.9x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($399.47 B vs $1.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COLL | ABBV |
|---|---|---|
| Market cap | $1.13 B | $399.47 B |
| US-listed rank | #2551 | #28 |
| Revenue (latest FY) | $780.57M | $61.16B |
| Net income (latest FY) | $63.00M | $4.23B |
| Net margin | 8.1% | 6.9% |
| P/E (trailing FY) | 17.9 | 94.5 |
| SEC filings | 849 | 1,008 |
AbbVie Inc. is 353.9x more valuable than COLLEGIUM PHARMACEUTICAL, INC by market capitalization ($399.47 B vs $1.13 B).
In their latest fiscal years, COLLEGIUM PHARMACEUTICAL, INC reported $780.57M in revenue while AbbVie Inc. reported $61.16B.
Full pages: COLLEGIUM PHARMACEUTICAL, INC and AbbVie Inc., or browse the full rankings.